The Home Infusion Therapy Market is projected to grow from USD 38.98 billion in 2024 to USD 71.82 billion by 2032, expanding at a robust CAGR of 8.36% during the forecast period (2025–2032). This growth is driven by the increasing prevalence of chronic diseases such as diabetes, cancer, and cardiovascular disorders, alongside a rising demand for cost-effective, patient-centric care solutions delivered in home settings.